Pro Share Advisors LLC Igm Biosciences, Inc. Transaction History

Pro Share Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$27.59 - $66.39 $179,610 - $432,198	-6,510 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$65.76 - $90.65 $11,836 - $16,317	-180 Reduced 2.69%	6,510 $428,000
Q2 2021 Aug 13, 2021	BUY	$57.98 - $96.6 $67,662 - $112,732	1,167 Added 21.13%	6,690 $557,000
Q1 2021 May 14, 2021	BUY	$71.56 - $121.23 $14,669 - $24,852	205 Added 3.85%	5,523 $424,000
Q4 2020 Feb 09, 2021	BUY	$47.41 - $115.03 $252,126 - $611,729	5,318 New	5,318 $470,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.